Identification of a Dual Inhibitor of Secreted Phospholipase A(2) (GIIA sPLA(2)) and SARS-CoV-2 Main Protease

The development of novel agents to combat COVID-19 is of high importance. SARS-CoV-2 main protease (M(pro)) is a highly attractive target for the development of novel antivirals and a variety of inhibitors have already been developed. Accumulating evidence on the pathobiology of COVID-19 has shown t...

Descripción completa

Detalles Bibliográficos
Autores principales: Theodoropoulou, Maria A., Koutoulogenis, Giorgos S., Zhang, Linlin, Akrani, Ifigeneia, Mikros, Emmanuel, Hilgenfeld, Rolf, Kokotos, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414318/
https://www.ncbi.nlm.nih.gov/pubmed/36015109
http://dx.doi.org/10.3390/ph15080961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414318/
https://www.ncbi.nlm.nih.gov/pubmed/36015109
http://dx.doi.org/10.3390/ph15080961

Ejemplares similares